AU5507786A - Process for the preparation of an antigen specific to herpes simplex virus type 2, agents suitable for this purpose, and the use of this antigen - Google Patents

Process for the preparation of an antigen specific to herpes simplex virus type 2, agents suitable for this purpose, and the use of this antigen

Info

Publication number
AU5507786A
AU5507786A AU55077/86A AU5507786A AU5507786A AU 5507786 A AU5507786 A AU 5507786A AU 55077/86 A AU55077/86 A AU 55077/86A AU 5507786 A AU5507786 A AU 5507786A AU 5507786 A AU5507786 A AU 5507786A
Authority
AU
Australia
Prior art keywords
antigen
herpes simplex
simplex virus
preparation
genome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU55077/86A
Other versions
AU592076B2 (en
Inventor
Egon Amann
Michael Broker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of AU5507786A publication Critical patent/AU5507786A/en
Application granted granted Critical
Publication of AU592076B2 publication Critical patent/AU592076B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Abstract

1. A process for the preparation of a polypeptide having antigenic determinants of the herpes simplex virus, by isolation of a section of the genome, which codes for this type of polypeptide, from the deoxyribonucleic acid of this virus, binding of the section of the genome enzymatically to the deoxyribonucleic acid of a vector, introduction of this combined deoxyribonucleic acid into a cell in which the combined deoxyribonucleic acid brings about the production of this polypeptide, and obtaining of this polypeptide, which process comprises the section of the genome being the Sall fragment (section of about 0.62 - 0.64 map units of the genome) of herpes simplex virus type 2.
AU55077/86A 1985-03-25 1986-03-24 Process for the preparation of an antigen specific to herpes simplex virus type 2, agents suitable for this purpose, and the use of this antigen Ceased AU592076B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3510734 1985-03-25
DE19853510734 DE3510734A1 (en) 1985-03-25 1985-03-25 METHOD FOR PRODUCING A HERPES SIMPLEX VIRUS TYPE 2-SPECIFIC ANTIQUE, MEANS THAT ARE SUITABLE FOR THIS, AND USE OF THIS ANTIQUE

Publications (2)

Publication Number Publication Date
AU5507786A true AU5507786A (en) 1986-10-02
AU592076B2 AU592076B2 (en) 1990-01-04

Family

ID=6266239

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55077/86A Ceased AU592076B2 (en) 1985-03-25 1986-03-24 Process for the preparation of an antigen specific to herpes simplex virus type 2, agents suitable for this purpose, and the use of this antigen

Country Status (6)

Country Link
EP (1) EP0199091B1 (en)
JP (1) JPS61227794A (en)
AT (1) ATE49999T1 (en)
AU (1) AU592076B2 (en)
DE (2) DE3510734A1 (en)
DK (1) DK135686A (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT77014B (en) * 1982-07-20 1986-01-24 Molecular Genetics Inc Production of herpes simplex viral proteins
AU1678783A (en) * 1982-07-20 1984-01-26 Molecular Genetics, Inc. Production of herpes simplex viral proteins
DE3228501A1 (en) * 1982-07-30 1984-02-02 Behringwerke Ag, 3550 Marburg METHOD FOR PRODUCING A HERPES ANTIGENT, MEANS THAT ARE SUITABLE FOR ITS PRODUCTION, AND METHOD FOR THE PRODUCTION THEREOF AND THE USE OF THIS ANTIQUE
US4475611A (en) * 1982-09-30 1984-10-09 Up-Right, Inc. Scaffold propulsion unit
US4745182A (en) * 1984-08-24 1988-05-17 University Patents, Inc. Herpes virus specific immunological materials and methods

Also Published As

Publication number Publication date
DK135686D0 (en) 1986-03-24
DK135686A (en) 1986-09-26
JPS61227794A (en) 1986-10-09
EP0199091A1 (en) 1986-10-29
ATE49999T1 (en) 1990-02-15
AU592076B2 (en) 1990-01-04
EP0199091B1 (en) 1990-01-31
DE3668642D1 (en) 1990-03-08
DE3510734A1 (en) 1986-09-25

Similar Documents

Publication Publication Date Title
ES8605039A1 (en) Vaccines based on membrane bound proteins and process for making them.
EP0175360A3 (en) Peptide antibodies and their use in detecting oncogene products
EP0217919A4 (en) Type-specific papillomavirus dna sequences and peptides.
EP0120551A3 (en) Yeast expression systems with vectors having gapdh or pyk promoters, and synthesis of foreign proteins
EP0752874A4 (en) Enhanced virus-mediated dna transfer
SG49097A1 (en) Nucleotide sequences coding for a protein with urease activity
AU2010288A (en) A process for synthesising his and trp containing peptides
MY101204A (en) Solubilization of protein aggregates
EP0088195A3 (en) Messenger rna, production and use thereof
EP0873049A4 (en)
IE860168L (en) Canine parvovirus vaccines
BR9500271A (en) Vector DNA sequence, plasmid, cell, protein, mutant process for the isolation of nucleic acids. Process for the preparation of sugars and use
AU1347688A (en) Viral antigen, process for its production, and application in diagnosis and therapy (vaccine)
ES8706824A1 (en) EXPRESSION AND DIAGNOSTIC USE OF gag ENCODED PEPTIDES WHICH ARE IMMUNOLOGICALLY REACTIVE WITH ANTIBODIES TO LAV.
IL69374A0 (en) Process for the preparation of a herpes antigen,an agent suitable for this and a process for its preparation,and the use of this antigen
PT97383A (en) Process for the production of a globin chain, a binding fragment thereof and haemoglobin, and haemoglobin compositions
EP0048455A3 (en) Synthetic dna and process therefor
EP0270930A3 (en) Substantially pure enzyme-antibody conjugate preparations
EP0293079A3 (en) Chlamydia vaccine
EP0177814A3 (en) Peptide antibodies and their use in detecting oncogene products
AU5507786A (en) Process for the preparation of an antigen specific to herpes simplex virus type 2, agents suitable for this purpose, and the use of this antigen
NZ213249A (en) Protein antigen, dna, plasmid, transformed microorganism and influenza vaccine
EP0207165A4 (en) Polypeptide secretion-causing vector, microorganisms transformed by said vector, and process for preparing polypeptide using said microorganisms.
EP0418626A3 (en) Fused proteins and production thereof
EP0112012A3 (en) Recombinant DNA molecules